Sanofi rated AA by Scope Ratings

Paris, France - September 7, 2017 - Sanofi announced today that the European ratings agency Scope Ratings AG ("Scope") assigned the company a AA long term rating and a S-1+ short-term rating. The outlook is stable.

These ratings confirm Sanofi's high credit quality and provide investors with an increased diversity of independent opinions.

Scope is accredited and regulated by the European Securities and Markets Authority. It is the third credit rating agency to rate Sanofi, as the company is already rated AA by Standard & Poor's and A1 by Moody's. Both ratings have stable outlooks.

About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Contacts:

Media Relations Laurence Bollack Tel. : +33 (0)1 53 77 46 46 mr@sanofi.com

Investor Relations George Grofik Tel.: +33 (0)1 53 77 45 45 ir@sanofi.com

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/45c5ffcc-43c1-48b7-abed-fd6c70f6f632

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.